| Fact Table | |
|---|---|
| Formula | C34H41N7O5 |
| License | FDA and EMA approved (2010) |
| Bioavailability | ~6–7% (oral; prodrug dabigatran etexilate) |
| Legal status | Prescription only (Rx) |
| Chemical Name | Ethyl N-{[2-({(4-{N-[(hexyloxy)carbonyl]-4-(pyridin-2-yl)benzamidine}amino)methyl}-1-methyl-1H-benzimidazol-5-yl)carbamoyl]pyridin-1-yl}carbamate |
| Elimination half-life | ~12–17 hours (longer in renal impairment) |
| Dosage (Strength) | 75 mg, 110 mg, and 150 mg oral capsules (usually twice daily) |
| Pregnancy | Category C – Use only if potential benefit justifies risk |
| Brands | Pradaxa (Boehringer Ingelheim), generics available |
| Protein binding | ~35% |
| PubChem CID | 135565 |
| MedlinePlus | a610024 |
| ChEBI | 70707 |
| ATC code | B01AE07 |
| DrugBank | DB06695 |
| KEGG | D09590 |
| Routes of administration | By mouth (oral capsules) |
Pradaxa (dabigatran) is a direct thrombin inhibitor anticoagulant used to reduce the risk of stroke and blood clots in adults and children. Dabigatran works by blocking thrombin, an enzyme that plays a role in the formation of blood clots. The medication is prescribed to decrease the risk of stroke in patients with nonvalvular atrial fibrillation, treat deep vein thrombosis and pulmonary embolism, and prevent blood clots after hip replacement surgery.
Take Pradaxa by mouth with or without food, swallowing the capsules whole with water. Don't break, chew, or open the capsules.
The standard dosage for preventing stroke in adults with atrial fibrillation is 150 mg twice daily. For patients with reduced kidney function, the dosage may be changed to 75 mg twice daily. When treating blood clots like deep vein thrombosis or pulmonary embolism, patients typically receive another blood thinner for 5 to 10 days before starting Pradaxa at 150 mg twice daily.
If a dose is missed, take it as soon as possible on the same day, but skip it if there are fewer than 6 hours until the next scheduled dose. Never take two doses at once to make up for a missed one. Patients should store Pradaxa in its original bottle and keep it tightly closed to protect it from moisture.
The active ingredient in Pradaxa is dabigatran.
Avoid taking or using this medication if any of the following apply:
Common side effects of Pradaxa include:
These side effects are usually related to irritation of the stomach and may improve over time. Taking Pradaxa exactly as prescribed can help reduce stomach discomfort. Let your healthcare provider know if digestive symptoms are persistent or bothersome.
More serious reactions can occur, including allergic reactions. Seek medical help right away if you develop chest tightness, trouble breathing or wheezing, swelling of the face or tongue, dizziness, or fainting. Contact your healthcare provider if you notice hives, rash, or itching, as these may be early signs of an allergic reaction.
What is Pradaxa (dabigatran)?
Pradaxa is a prescription anticoagulant, also known as a blood thinner. It is used to reduce the risk of stroke and blood clots in certain people with atrial fibrillation not caused by a heart valve problem, and to treat or prevent deep vein thrombosis and pulmonary embolism.
How does Pradaxa work?
Pradaxa works by directly inhibiting thrombin, an enzyme in the blood that is essential for clot formation. By blocking thrombin, it helps prevent existing clots from growing and new clots from forming.
What conditions is Pradaxa commonly prescribed for?
Pradaxa is commonly prescribed to prevent stroke in people with non-valvular atrial fibrillation and to treat or prevent blood clots in the legs (deep vein thrombosis) or lungs (pulmonary embolism), including after certain surgeries or prior clotting events.
How is Pradaxa taken?
Pradaxa is taken by mouth, usually twice daily. The capsules must be swallowed whole, as opening, chewing, or breaking them can increase the risk of bleeding.
What are the most common side effects of Pradaxa?
Common side effects of Pradaxa include stomach pain, indigestion, heartburn, nausea, and an increased tendency to bruise or bleed more easily.
What are serious side effects to watch for?
Serious side effects may include unusual or prolonged bleeding, blood in the urine or stools, coughing or vomiting blood, severe weakness, or sudden dizziness. These symptoms require immediate medical attention.
Who should not take Pradaxa?
Pradaxa may not be suitable for people with active bleeding, severe kidney disease, mechanical heart valves, or a known allergy to dabigatran. A healthcare provider should evaluate individual risks before prescribing it.
Does Pradaxa require routine blood testing?
Unlike some older blood thinners, Pradaxa does not usually require routine blood tests to monitor clotting levels. However, kidney function may be checked periodically.
Can Pradaxa interact with other medications?
Pradaxa can interact with other medications, including certain blood thinners, heart medications, antifungals, and antibiotics. These interactions may increase the risk of bleeding, so it is important to inform your healthcare provider of all medicines you take.
What should be known about stopping Pradaxa?
Stopping Pradaxa suddenly can increase the risk of stroke or blood clots. It should only be stopped or changed under the guidance of a healthcare provider.
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (e.g., different shape or color), as trademark laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.